Preparation of dendritic cell tumor-vaccine with dendritic cells and problems in its clinical uses--review / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 397-400, 2004.
Article
in Chinese
| WPRIM
| ID: wpr-352055
ABSTRACT
Dendritic cell (DC), the most powerful antigen presenting cell, has been paid close attention to tumor immunotherapy. The tumor antigens were extracted by different ways to pulse DC, and then the mature DC were infused to patients to accelerate anti-tumor immuno responses. Its clinical use would provide a new therapeutic pathway other than surgical operation, irradiation, chemotherapy. In this paper, biological characteristics of DC, tumor-vaccine preparation and its clinical use were reviewed.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Therapeutics
/
Dendritic Cells
/
Cell Culture Techniques
/
Cancer Vaccines
/
Allergy and Immunology
/
Neoplasms
Limits:
Humans
Language:
Chinese
Journal:
Journal of Experimental Hematology
Year:
2004
Type:
Article
Similar
MEDLINE
...
LILACS
LIS